SITC (Society for Immunotherapy of Cancer) 2022

Boston Boston, Massachusetts, Förenta Staterna, USA

Malin Lindstedt, visiting professor at Alligator Bioscience and Professor at the Department of Immunotechnology at Lund University, will give a poster presentation entitled “Early pharmacodynamic changes measured by RNA sequencing in peripheral blood from patients in a phase 1 study with mitazalimab, a potent CD40 agonistic IgG1 monoclonal antibody”, poster number 35, on November 10. […]

Redeye Life Science Day, Stockholm

Virtuellt

Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

Biostock Life Science Fall Summit 2022

Medicon Village Medicon Village, Lund, Sverige

Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will give a corporate presentation followed by a Q&A session at 1:00 pm CET on November 30.

13th Annual DNB Nordic Healthcare Conference

Oslo Oslo, Norge

Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

ØU Life Science Investor Conference

Köpenhamn Köpenhamn, Danmark

Søren Bregenholt, Chief Executive Officer of Alligator Bioscience, will present the company, its latest developments, and upcoming catalysts to investors.

European Bispecific & Multispecific Antibody Congress

Amsterdam Amsterdam, Nederländerna

Laura von Schantz, Vice President of Discovery at Alligator Bioscience, will give a presentation entitled "Reviewing the Landscape of Obligate MoAs for Bi-/Multispecifics to Prioritise and De-Risk Current and Future Efforts" at 2.30 pm CET on February 22.